EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca and Daiichi's Datroway: Groundbreaking Lung Cancer Treatment Approved in the US, ETPharma
US FDA Nod: AstraZeneca, Daiichi's Datroway Approved for Lung Cancer Treatment
AstraZeneca's Datroway Approved to Treat Non-Small Cell Lung Cancer in U.S. | Morningstar
US approves AstraZeneca, Daiichi's treatment for lung cancer
AstraZeneca To Pay $45 Mln To Daiichi Sankyo As Datroway Gets FDA Approval For Lung Cancer
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types
BMJ investigation raises new concerns over ticagrelor approval trials
Sivik Global Healthcare LLC Acquires New Holdings in AstraZeneca PLC (NASDAQ:AZN)
First American Bank Has $1.81 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant
Ex McDonald's Korea CEO to take leading role in Homeplus
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Buy" from Analysts
New Swedish research initiative targets obesity and metabolic diseases
3,555 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Wolf Group Capital Advisors
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China | The Manila Times
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China | Morningstar
AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma focused on AI-enabled research in China
NodThera Announces Appointment of Elisabeth Björk as Board Member | The Manila Times
ADC cancer drugs: Pfizer, AstraZeneca, Merck bet on chemo replacement
NodThera Announces Appointment of Elisabeth Björk as Board Member | Morningstar
Inscription Capital LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)
Montecito Bank & Trust Purchases 4,328 Shares of AstraZeneca PLC (NASDAQ:AZN)
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
)
Sphere Bio further expands Cambridge-China's new Silk Road of trade
Second liver failure death surfaces with Sarepta's Elevidys in DMD | BioWorld
Zacks Research Forecasts Weaker Earnings for AstraZeneca
Astrazeneca makes $5.3B drug R&D pact with CSPC | BioWorld
CSPC and Astrazeneca establish strategic research collaboration | BioWorld
BRICS and the Pandemic Agreement
AstraZeneca's ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
New Century Financial Group LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)
Elevation Point Wealth Partners LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)
5 top FTSE 100 stocks offering plenty of global growth for an ISA
Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025 | Morningstar
Vietnamese PM works with top Swedish firms to foster investment ties
Stanley Laman Group Ltd. Purchases 9,614 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca signs AI research deal with China's CSPC for chronic diseases - The Economic Times
AstraZeneca Signs Nearly $5.3 Bln AI-enabled Research Deal With China's CSPC Pharma
AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction
Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma
Swedish businesses asked to expand investment in Vietnam
8 Best Inexpensive Stocks to Buy Right Now
Alexion Owes Another $181M for Lack of Commercially Reasonable Efforts in Milestone Earnout Case, Chancery Rules
Cutaneous Lupus Erythematosus Market Research Report 2025-2035 - Biologic Innovations and Rising Autoimmune Incidence Fuel Growth
Assenagon Asset Management S.A. Sells 74,715 Shares of AstraZeneca PLC (NASDAQ:AZN)
RFK Jr. names new CDC vaccine advisory panel picks, STAT reports | Markets Insider
IonQ (NYSE:IONQ) Advances Quantum Computing With New Healthcare Collaboration
Merck wins approval FDA in pediatric RSV and steps into CDC uncertainty | BioWorld
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease | Morningstar
News: AstraZeneca India appoints Praveen Rao Akkinepally new MD - People Matters
AstraZeneca Pharma slides as MD Sanjeev Panchal steps down; Praveen Rao Akkinepally to take charge | Capital Market News - Business Standard
FDA Approves Merck's RSV Antibody for Infants | Newsmax.com
US FDA approves Merck's RSV antibody for infants | U.S. & World | gazette.com
NBC Securities Inc. Purchases 3,837 Shares of AstraZeneca PLC (NASDAQ:AZN)
Merit Financial Group LLC Acquires 14,743 Shares of AstraZeneca PLC (NASDAQ:AZN)
M42, AstraZeneca & SOPHiA GENETICS launch liquid biopsy initiative in UAE
FTSE 100 shares to consider buying for a well balanced Stocks and Shares ISA
Fermata Advisors LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)
Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial
Foreign firms deepen roots, strive for localization
Chesley Taft & Associates LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)
Article: Future-Ready by Design: AstraZeneca India's HR Playbook for Talent-Led Growth in GCCs - People Matters
An end-to-end attention-based approach for learning on graphs
)
AstraZeneca, BioNTech and CIC back Sortera Bio's £7.5m pre-seed round
The current and emerging immunotherapy paradigm in small-cell lung cancer
The People-First Liver Charter
AstraZeneca CEO suggests cause behind high drug prices
74,997 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Nixon Peabody Trust Co.
GAMMA Investing LLC Buys 573,535 Shares of AstraZeneca PLC (NASDAQ:AZN)
Trixeo Aerosphere approved in the UK as first inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential
Win for Added Relacorilant in Platinum-Resistant Ovarian Cancer
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
Healthy Returns: AstraZeneca, Pfizer, Gilead release cancer drug data
UK Stocks That Might Be Priced Below Estimated Value
Daiichi Sankyo, AstraZeneca Announce Promising DATROWAY Combination Data in NSCLC
AstraZeneca CEO on breast cancer drug trial: This is the future of cancer treatment
AstraZeneca pill helps cut breast cancer progression risk
Experimental AstraZeneca pill helps cut risk of breast cancer progression
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
52 week high stocks: Stock market update: Stocks that hit 52-week lows on NSE in today's trade - The Economic Times
AstraZeneca Reports Encouraging Data For Enhertu As 1st-line Treatment Of HER2+ Breast Cancer
Stocks to watch today, June 2: Vi, Nykaa, IndiGo, Adani Energy, AstraZeneca | Markets News - Business Standard
Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
AstraZeneca, Daiichi announce results from three trials on DATROWAY | Markets Insider
AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI | Markets Insider
AstraZeneca announces results from SERENA-6 Phase III trial | Markets Insider
AstraZeneca breast cancer medicine slows disease by over six months
Blood test-guided treatment cuts breast cancer risk | Seymour Telegraph
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
AstraZeneca News
Latest news
Show more
Morning Note: Mideast Tensions Drive Oil & Gold Volatility; Tesla Rolls Out Robotaxi
Global tensions impacted crypto market: BTC over $100K, Cardano around $0.54
